In a previous series of short articles, we profiled Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney. Here we add another worthy Australian city to the list, Adelaide. One of the perils of writing a ‘four-part series’ on Australia is that the country boasts a veritable multitude of…

Read More

In a recent publication, the New Zealand government has expressed a clear description of what it expects of its growing science and innovation system. ‘Excellence’ and ‘Impact’ will be the main criteria for public investment. All science should have a strong line-of-sight of the eventual benefits to businesses and society. The government aims to increase…

Read More

One of our Executive Directors, Dr Andrew Kelly, this month accepted an invitation to join the Board of a $135 million research program on High Value Nutrition, part of the New Zealand National Science Challenge system. The Challenge is a 10-year, mission-led research program where researchers from across multiple Universities and research institutes come together…

Read More

Green-lipped mussels are New Zealand’s leading aquaculture product. In raw product alone, mussel farmers exported 34,000 tons worth NZD 190M in 2012. Green-lipped mussel extract, which is used in supplements and biopharmaceuticals, generates additional revenues of around NZD 40M. Green lipped mussel extract is well known for its anti-inflammatory properties associated with joint pain, arthritis,…

Read More

NZBIO, Wellington NZBIO 2015, held in the ‘southernmost capital city in the world’, Wellington, New Zealand recently, was an excellent conference this year. A change of city, a great venue (our national Museum, Te Papa) and an up-tick on attendances compared to recent years all created a great vibe. And it was excellent for BioPacific…

Read More

ABIC 2015 This year’s Agricultural Bioscience International Conference found a welcoming home in Melbourne, Australia. Multinationals such as Bayer CropScience, Monsanto, Syngenta, and Pepsi, mingled with research groups and businesses from Australasia including CSIRO, AgResearch, and a full complement of universities. The three-day conference explored the thorny issues around innovation in agritech, its global applications, and public perception….

Read More

Part four of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney. New South Wales is home to approximately 200 life science companies and exports over AUD2 billion (USD1.4 billion) in pharmaceuticals and medical devices annually….

Read More

Part three of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney.   Queensland, and its capital city Brisbane, are well known both in Australia and globally for their strengths in pre-farm gate technology, tropical health,…

Read More

Part two of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney. Melbourne is globally recognised for its strengths in clinical trials, stem cell research and cancer therapies. Greater Melbourne includes 27 biotechnology research institutes, nine…

Read More

Part one of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney. The latest Scientific American Worldview Scorecard 2015 ranked Australia number four in biotechnology in the world. Significantly, Scientific American commented that if ranking was…

Read More